[go: up one dir, main page]

AU2001254813A1 - Regulation of nf-at interacting protein nip 45 variant - Google Patents

Regulation of nf-at interacting protein nip 45 variant

Info

Publication number
AU2001254813A1
AU2001254813A1 AU2001254813A AU5481301A AU2001254813A1 AU 2001254813 A1 AU2001254813 A1 AU 2001254813A1 AU 2001254813 A AU2001254813 A AU 2001254813A AU 5481301 A AU5481301 A AU 5481301A AU 2001254813 A1 AU2001254813 A1 AU 2001254813A1
Authority
AU
Australia
Prior art keywords
nip
interacting protein
variant
regulation
activation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001254813A
Other languages
English (en)
Inventor
Jeffrey Encinas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2001254813A1 publication Critical patent/AU2001254813A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Dairy Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2001254813A 2000-04-25 2001-04-25 Regulation of nf-at interacting protein nip 45 variant Abandoned AU2001254813A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19935600P 2000-04-25 2000-04-25
US60199356 2000-04-25
PCT/EP2001/004635 WO2001081574A2 (fr) 2000-04-25 2001-04-25 Regulation de variante de proteine nip 45 a interaction avec nf-at

Publications (1)

Publication Number Publication Date
AU2001254813A1 true AU2001254813A1 (en) 2001-11-07

Family

ID=22737188

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001254813A Abandoned AU2001254813A1 (en) 2000-04-25 2001-04-25 Regulation of nf-at interacting protein nip 45 variant

Country Status (8)

Country Link
EP (1) EP1280897B1 (fr)
JP (1) JP2003530883A (fr)
AT (1) ATE340261T1 (fr)
AU (1) AU2001254813A1 (fr)
DE (1) DE60123235T2 (fr)
DK (1) DK1280897T3 (fr)
ES (1) ES2272471T3 (fr)
WO (1) WO2001081574A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002214005A1 (en) * 2000-10-10 2002-04-22 Bayer Aktiengesellschaft Regulation of nf-at interacting protein nip 45 like protein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1225682A (zh) * 1996-04-23 1999-08-11 哈佛大学校长及研究员协会 通过调节转录因子活性调节t细胞亚群
GB9722388D0 (en) * 1997-10-24 1997-12-24 Zeneca Ltd NIP45 human homolog

Also Published As

Publication number Publication date
DE60123235D1 (de) 2006-11-02
ES2272471T3 (es) 2007-05-01
ATE340261T1 (de) 2006-10-15
WO2001081574A3 (fr) 2002-04-18
DE60123235T2 (de) 2007-09-13
EP1280897A2 (fr) 2003-02-05
WO2001081574A2 (fr) 2001-11-01
DK1280897T3 (da) 2007-01-08
JP2003530883A (ja) 2003-10-21
EP1280897B1 (fr) 2006-09-20

Similar Documents

Publication Publication Date Title
AU2002365811A1 (en) Methods for the selection and cloning of nucleic acid molecules free of unwanted nucleotide sequence alterations
MXPA02012743A (es) Moleculas tipo il-17 y usos de las mismas.
WO2000069896A3 (fr) Interactions moleculaires dans les cellules hematopoietiques
WO2004043407A3 (fr) Methodes et produits de traitement des infections staphylococciques
EP1808180A3 (fr) GP 100 modifié et ses utilisations
WO2002014485A3 (fr) Nouveau gene kallikreine
WO2001048209A3 (fr) Genes identifies comme etant requis pour la proliferation de e.coli
WO2000053776A3 (fr) Nouveaux genes humains du type kallikreine
WO2002040668A3 (fr) Proteines et sequences d'adn sous-jacentes a ces proteines, utilisees pour traiter les inflammations
WO2003040181A3 (fr) Genes codant des proteines de regulation
WO2003046123A3 (fr) Genes codant de nouvelles proteines
WO1998010076A3 (fr) Sequences d'adn et phospholipase d
WO2001040313A3 (fr) Proteines immunoregulatrices felines, molecules d'acide nucleique et leurs utilisations
AU2001254813A1 (en) Regulation of nf-at interacting protein nip 45 variant
WO2002031512A3 (fr) Interactions moleculaires dans des cellules hematopoietiques
WO2002030972A3 (fr) Regulation de proteines de type proteine nip 45 a interaction avec nf-at
PL374550A1 (en) Il-17 like molecules and uses thereof
WO2001085935A3 (fr) Recepteur couple a une proteine g du type du gene 6 de differenciation endotheliale
WO2003002599A3 (fr) Proteines jouant un role dans l'immunite et leur regulation
PT1322753E (pt) Novas redutases do acido 2,5-diceto-l-gluconico e metodos de utilizacao
WO2001039786A3 (fr) Nouvelles utilisations des facteurs d'activation des macrophages suppresseurs
WO2009083968A8 (fr) Nouvelle protéine
WO2000069898A3 (fr) Interactions moleculaires dans les reactions allergiques
WO2001077348A3 (fr) Plasmides endogenes de $m(f)i$m(g)ketogulonigenium$m(f)/i$m(g)
AU2002323612A1 (en) Novel clark protein and nucleic acid molecules and uses therefor